Evotec SE (EVO) Common Equity (2019 - 2025)
Evotec SE's (EVO) quarterly Common Equity came in at $947.2 million in Q4 2025, down 6.94% year-on-year from $1.0 billion in Q4 2024, and down 6.94% quarter-over-quarter from $1.0 billion in Q4 2024.
Evotec SE (EVO) Common Equity (2019 - 2025) Analysis & Trends
Evotec SE has disclosed Common Equity across 7 years of filings, most recently posting $947.2 million for Q4 2025.
- Common Equity for Q4 2025 came in at $947.2 million, down 6.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $947.2 million (down 6.94% YoY), and the FY2025 annual result was $947.2 million, down 6.94% from the prior year.
- Common Equity came in at $947.2 million for Q4 2025 at Evotec SE, down from $1.0 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.6 billion in Q4 2021 to a low of $1.1 million in Q3 2024.
- The 5-year median for Common Equity is $1.1 billion (2024), against an average of $993.1 million.
- Across the five-year window, Common Equity jumped 82.46% in 2021 and decreased 23.15% in 2022, its largest moves.
- Evotec SE's Common Equity stood at $1.6 billion in 2021, then slipped by 23.15% to $1.2 billion in 2022, then declined by 0.52% to $1.2 billion in 2023, then fell by 15.53% to $1.0 billion in 2024, then dropped by 6.94% to $947.2 million in 2025.
- The last three Common Equity figures came in at $947.2 million (Q4 2025), $1.0 billion (Q4 2024), and $1.1 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 947.19 Mn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Dec 31, 2020 | 863.76 Mn |
| Dec 31, 2019 | 529.77 Mn |